The drug may be a risk factor for dementia-related illnesses.
Jolene Bressi, PhamD, PMP, BCMAS
Advertisement
Articles by Jolene Bressi, PhamD, PMP, BCMAS
The safety and efficacy of long-term benzodiazepine use beyond the recommended timeframe is not well understood.
Misconceptions about the diagnosis of attention-deficit hyperactivity disorder reduce the credibility of health care providers and delay or prevent treatment for patients suffering from this condition.
Advertisement
Latest Updated Articles
Cognitive Consequences of Benzodiazepine Use: Is it Worth Losing Our Mind Over?Published: July 6th 2023 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
FDA Initiates Approval of Leucovorin for Patients With Cerebral Folate Deficiency
2
Rapid CAR T Expansion Linked to Delayed Neurotoxicity in Patients Treated With Cilta-Cel
3
Hercessi, Biosimilar to Herceptin, Shows Favorable Efficacy, Safety in Treating HER2+ MBC in Real-World Setting
4
IMS: Shaping the Future of Multiple Myeloma with Anti-CD38 Quadruplets
5
